Pricing Log in Create free account

Satellos Bioscience Inc. (MSLE) vs NervGen Pharma Corp. (NGEN)

Satellos Bioscience Inc. and NervGen Pharma Corp. are both Biotechnology companies. Satellos Bioscience Inc. and NervGen Pharma Corp. are of similar size ($152.6M and $143.1M). Across the 8 metrics below, Satellos Bioscience Inc. leads on 4 and NervGen Pharma Corp. on 4.

Valuation

Metric MSLE NGEN Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.50 3.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (27.50%) (17.89%) (32.88%)
Free cash flow yield (19.37%) (14.96%) (23.13%)

Profitability

Metric MSLE NGEN Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (70.45%) (94.85%) (51.96%)
Return on assets (64.76%) (40.66%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MSLE NGEN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 21.20% (68.14%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MSLE NGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 2.07 4.97
Net debt to EBITDA 1.05 0.95 1.01

Dividend

Metric MSLE NGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MSLE NGEN Biotechnology median
Market cap 152.57m 143.13m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack